266 related articles for article (PubMed ID: 27976800)
1. Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.
Zhang F; Hu L; Wang J; Chen J; Chen J; Wang Y
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27976800
[TBL] [Abstract][Full Text] [Related]
2. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL
J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.
Zhang F; Wang J; Zheng X; Hu L; Chen J; Jiang F; Wang Y
J Clin Lab Anal; 2018 Oct; 32(8):e22576. PubMed ID: 29797475
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
Zhang F; Wang J; Fu J; Hu L; Zheng X; Wang Y; Chen B
J Clin Lab Anal; 2020 Mar; 34(3):e23091. PubMed ID: 31709646
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.
Zhao T; Zhang J; Zhang X; Wang C
BMC Pulm Med; 2024 May; 24(1):241. PubMed ID: 38750432
[TBL] [Abstract][Full Text] [Related]
6. A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.
Saraya T; Ohkuma K; Koide T; Goto H; Takizawa H; Light RW
Medicine (Baltimore); 2019 Mar; 98(13):e15003. PubMed ID: 30921217
[TBL] [Abstract][Full Text] [Related]
7. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
Li R; Gao Z; Dong K; Wang H; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of tuberculous and malignant pleural effusions: comparison of the Th1/Th2 cytokine panel, tumor marker panel and chemistry panel.
Zhang J; Chen Y; He G; Jiang X; Chen P; Ouyang J
Scand J Clin Lab Invest; 2020 Jul; 80(4):265-270. PubMed ID: 32108543
[TBL] [Abstract][Full Text] [Related]
11. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
12. Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.
Zhang Y; Li X; Liu J; Hu X; Wan C; Zhang R; Shen Y
Ann Med; 2021 Dec; 53(1):558-566. PubMed ID: 33818231
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing malignant pleural effusion using clinical and analytical parameters.
Pan Y; Bai W; Chen J; Mao Y; Qian X; Xu K; Tang S; Zhang J; Chen C; Chen J; Hu X
J Clin Lab Anal; 2019 Feb; 33(2):e22689. PubMed ID: 30390322
[TBL] [Abstract][Full Text] [Related]
14. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
[TBL] [Abstract][Full Text] [Related]
15. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase-based measurement in the differential diagnosis of pleural effusion: a multicenter retrospective study.
Gao L; Wang W; Zhang Y; Hu X; An J; Li Y; Chen M; Shen Y
Ther Adv Respir Dis; 2023; 17():17534666231155747. PubMed ID: 36846945
[TBL] [Abstract][Full Text] [Related]
18. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
Yildiz PB; Yazar EE; Gorgun D; Secik F; Cakir G
Asian Pac J Cancer Prev; 2011; 12(2):419-23. PubMed ID: 21545206
[TBL] [Abstract][Full Text] [Related]
19. The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions.
Wang J; Liu J; Xie X; Shen P; He J; Zeng Y
BMC Pulm Med; 2017 Dec; 17(1):168. PubMed ID: 29202740
[TBL] [Abstract][Full Text] [Related]
20. Role of biochemical tests in the diagnosis of exudative pleural effusions.
Ernam D; Atalay F; Hasanoglu HC; Kaplan O
Clin Biochem; 2005 Jan; 38(1):19-23. PubMed ID: 15607312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
